Phase Ⅰ Clinical Trial of a Candidate COVID-19 Vaccine
Clinical trial NCT05706324 · UNKNOWN
Trial details
- NCT number
- NCT05706324
- Sponsor
- Wuhan BravoVax Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-01
- Primary completion
- 2023-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.